Literature DB >> 8168975

Monoclonal antibodies to the circumsporozoite protein repeats of a Plasmodium vivax-like human malaria parasite and Plasmodium simiovale.

V Udhayakumar1, S H Qari, P Patterson, W E Collins, A A Lal.   

Abstract

We have recently described a Plasmodium vivax-like human malaria parasite. The circumsporozoite protein of this parasite is identical to that of a simian malaria parasite, P. simiovale, but different from two known types of P. vivax. Here, we describe the production of two monoclonal antibodies, Pam 172 and Pam 135, specific for the circumsporozoite protein repeat sequence APGANQEGGAA of the P. vivax-like malaria parasite. These two monoclonal antibodies recognized air-dried sporozoites of P. simiovale but not other human, simian, or rodent malaria parasites tested.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8168975      PMCID: PMC186472          DOI: 10.1128/iai.62.5.2098-2100.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  SIMIAN MALARIA PARASITES OF CEYLON.

Authors:  A S DISSANAIKE
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

2.  An improved conjugation method for controlled covalent coupling of synthetic peptides to proteins using glutaraldehyde in a dialysis method.

Authors:  N Zegers; K Gerritse; C Deen; W Boersma; E Claassen
Journal:  J Immunol Methods       Date:  1990-07-03       Impact factor: 2.303

3.  Identification of Plasmodium vivax sporozoites in mosquitoes using an enzyme-linked immunosorbent assay.

Authors:  R A Wirtz; T R Burkot; R G Andre; R Rosenberg; W E Collins; D R Roberts
Journal:  Am J Trop Med Hyg       Date:  1985-11       Impact factor: 2.345

4.  Circumsporozoite protein of the human malaria parasite Plasmodium ovale identified with monoclonal antibodies.

Authors:  P M Procell; W E Collins; G H Campbell
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

5.  Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax.

Authors:  R Rosenberg; R A Wirtz; D E Lanar; J Sattabongkot; T Hall; A P Waters; C Prasittisuk
Journal:  Science       Date:  1989-09-01       Impact factor: 47.728

6.  Monoclonal antibodies produced against sporozoites of the human parasite Plasmodium malariae abolish infectivity of sporozoites of the simian parasite Plasmodium brasilianum.

Authors:  A H Cochrane; J W Barnwell; W E Collins; R S Nussenzweig
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

7.  Identification of Plasmodium vivax-like human malaria parasite.

Authors:  S H Qari; Y P Shi; I F Goldman; V Udhayakumar; M P Alpers; W E Collins; A A Lal
Journal:  Lancet       Date:  1993-03-27       Impact factor: 79.321

8.  Circumsporozoite protein of Plasmodium vivax: gene cloning and characterization of the immunodominant epitope.

Authors:  D E Arnot; J W Barnwell; J P Tam; V Nussenzweig; R S Nussenzweig; V Enea
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

9.  Sequence of the immunodominant epitope for the surface protein on sporozoites of Plasmodium vivax.

Authors:  T F McCutchan; A A Lal; V F de la Cruz; L H Miller; W L Maloy; Y Charoenvit; R L Beaudoin; P Guerry; R Wistar; S L Hoffman
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

10.  Global occurrence of Plasmodium vivax-like human malaria parasite.

Authors:  S H Qari; Y P Shi; M M Povoa; M P Alpers; P Deloron; G S Murphy; S Harjosuwarno; A A Lal
Journal:  J Infect Dis       Date:  1993-12       Impact factor: 5.226

View more
  2 in total

Review 1.  Host Cell Tropism and Adaptation of Blood-Stage Malaria Parasites: Challenges for Malaria Elimination.

Authors:  Caeul Lim; Selasi Dankwa; Aditya S Paul; Manoj T Duraisingh
Journal:  Cold Spring Harb Perspect Med       Date:  2017-11-01       Impact factor: 6.915

2.  Circumsporozoite protein as a potential target for antimalarials.

Authors:  Cristina Fernández-Arias; Sara Mashoof; Jing Huang; Moriya Tsuji
Journal:  Expert Rev Anti Infect Ther       Date:  2015-06-16       Impact factor: 5.091

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.